With an annual 150,000 deaths and countless amputations and disfigurements,snakebite envenoming is an ever-present threat in many parts of the rural tropicalworld. In sub-Saharan Africa, only 1-2% of victims are treated with antivenom,which is currently based on animal-derived antibodies. Due to their heterologousorigin, antivenoms often provoke serious side effects in human recipients, such asserum sickness and anaphylaxis, which in some cases leads to death.
|Number of pages||1|
|Publication status||Published - 2016|
|Event||Symposium for Biological and Life Science Students (SymBLS) 2016 - Cambridge, United Kingdom|
Duration: 25 Nov 2016 → 25 Nov 2016
|Conference||Symposium for Biological and Life Science Students (SymBLS) 2016|
|Period||25/11/2016 → 25/11/2016|